Search Results 7051-7060 of 25204 for oral

  1. Mayo Clinic Radio: Genitourinary syndrome of menopause

    On this encore presentation of Mayo Clinic Radio, two previously aired segments will be revisited on the program. First, women's health expert Dr. Stephanie ...

  2. Publications - Melanie L. Lyden, M.D. - Mayo Clinic

    Oral Maxillofac Surg. 2024 Jun; 28 (2):723-728 Epub 2023 Nov 22. View PubMed; Lund S, Schmitz JJ, Foster T, Dy B, McKenzie T, Castro MR, Lyden ML. Ethanol ...

  3. Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) - Mayo Clinic

    Highly effective forms of contraception are defined as hormonal oral contraceptives, injectables, patches, intrauterine devices, intrauterine hormone ...

  4. Publications - Imad Absah, M.D. - Mayo Clinic

    The Role of Oral Administration of Immunoglobulin in Managing Diarrheal Illness in Immunocompromised Children. Paediatr Drugs. 2020 Jun; 22 (3):331-334. View ...

  5. Spinal cord tumor - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  6. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Radiation Oncology ...

  7. Publications - Hatem Amer, M.D. - Mayo Clinic

    Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial. Am J Transplant. 2013 Jun; 13 (6): ...

  8. Rhabdomyosarcoma - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  9. Clinical trials - Oncology (Medical)

    Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

  10. A Trial Investigating the Safety, Tolerability and Effectiveness of TransCon PTH Administered Daily in Adults With Hypoparathyroidism - Mayo Clinic

    Use of osteoporosis therapies known to influence calcium and bone metabolism; i.e., bisphosphonate (oral or intravenous [IV]), denosumab, raloxifene, or ...